As illnesses mount, officials warn of e-cigarette dangers
Published 9:18 pm Wednesday, September 18, 2019
By Georgia Geen
Capital News Service
When cases of lung disease linked to vaping began popping up across the country this summer, the Virginia Poison Center began receiving calls from people who thought they might have become ill from using e-cigarettes.
Email newsletter signup
“Nobody knows why there’s all of a sudden been a cluster,” said Dr. S. Rutherfoord Rose, director of the Virginia Poison Center. “There is an inherent danger, and nobody really knows what that danger is. If you’re young and healthy, why risk it? Just stop.”
Last week, the Trump administration moved to ban flavored vapes in response to the spike in lung illnesses, the latest in a series of measures nationwide aimed at curbing e-cigarette use. This summer, a Virginia law went into effect that increased the age to buy cigarettes and other tobacco products from 18 to 21.
Virginia is one of dozens of states with reports of vaping-related illness. Nationwide, officials have linked 380 cases of lung disease and six deaths to e-cigarettes.
Altria Group, the Henrico-based conglomerate that produces and sells tobacco and related products, is a top investor in Juul Labs Inc., maker of the popular Juul e-cigarettes. Earlier this month, the U.S. Food and Drug Administration warned Juul about its marketing practices, “including those targeted at students, tribes, health insurers and employers.”
“We agree that urgent action is needed, and we look forward to reviewing the guidance,” Altria spokesman George Parman said in an email. “Reducing youth use of e-vapor products is a top priority for Altria.”
Vaping often has been cast as a safe alternative to cigarettes. But Rose, who is also a professor at the VCU School of Medicine, said that because the products are so new, there is a lack of data on the long-term use of vaping. As a result, it’s “premature” to say e-cigarettes are indeed safer, Rose said.
“When these things were touted as a safe alternative to cigarettes, that was really only based on the harmful effects of long-term cigarettes. It really wasn’t a comparison, because there wasn’t any data,” Rose said. “There’s certainly no data for long-term use of these products; they haven’t been around long enough.”
Using vapes early on can lead young people to smoke cigarettes in the future, according to a 2015 study. And data shows more people have picked up vaping in recent years. Nationally, the rate of current e-cigarette use among high school students increased to almost 21 percent in 2018, according to the CDC.
The U.S. Centers for Disease Control and Prevention has compiled data on e-cigarette use in 37 states and U.S. territories in 2017. The data showed that:
4About 33 percent of Virginia high school students had used an electronic cigarette at some point. That compared with about 42 percent of high school students nationwide.
4About 12 percent of high schoolers in Virginia were current vape users, just below the national average of 13 percent. (The CDC defines a current user as someone who has vaped at least once during the past 30 days.)
4About 3 percent of the state’s high school students vaped frequently. That was on par with the national average. (A frequent user is someone who has used e-cigarettes at least 20 days during the past month.)
4About 10 percent of Virginia’s young adults (ages 18-24) were current e-cigarette users. That also was about the national average.
Last week, the FDA announced it had found a commonality — the presence of vitamin E acetate — among users who had fallen ill after vaping cannabis products. But Rose said it could take months or years to understand the cause of the outbreak, which he expects will grow before the situation improves.
The wide scope of products people are using — some of which contain nicotine or THC, and are purchased at stores or illicitly — makes it more challenging to narrow down an exact cause.
“There are a variety of products out there, people putting a variety of ingredients in those products,” Rose said. “So there’s not a lot of uniformity. There’s some common themes but not to all patients who have developed the problem.”